GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DiaMedica Therapeutics Inc (NAS:DMAC) » Definitions » Cyclically Adjusted Book per Share

DiaMedica Therapeutics (DiaMedica Therapeutics) Cyclically Adjusted Book per Share : $0.75 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is DiaMedica Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

DiaMedica Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was $1.221. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.75 for the trailing ten years ended in Mar. 2024.

During the past 12 months, DiaMedica Therapeutics's average Cyclically Adjusted Book Growth Rate was 21.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -5.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of DiaMedica Therapeutics was -5.90% per year. The lowest was -19.50% per year. And the median was -16.50% per year.

As of today (2024-05-24), DiaMedica Therapeutics's current stock price is $2.85. DiaMedica Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.75. DiaMedica Therapeutics's Cyclically Adjusted PB Ratio of today is 3.80.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of DiaMedica Therapeutics was 9.31. The lowest was 1.01. And the median was 2.88.


DiaMedica Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for DiaMedica Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DiaMedica Therapeutics Cyclically Adjusted Book per Share Chart

DiaMedica Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 0.84 0.68 0.63 0.70

DiaMedica Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.65 0.69 0.70 0.75

Competitive Comparison of DiaMedica Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, DiaMedica Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DiaMedica Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DiaMedica Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DiaMedica Therapeutics's Cyclically Adjusted PB Ratio falls into.



DiaMedica Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DiaMedica Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.221/131.7762*131.7762
=1.221

Current CPI (Mar. 2024) = 131.7762.

DiaMedica Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.028 100.560 0.037
201409 -0.229 100.428 -0.300
201412 -0.493 99.070 -0.656
201503 -0.405 99.621 -0.536
201506 -0.242 100.684 -0.317
201509 -0.295 100.392 -0.387
201512 -0.300 99.792 -0.396
201603 -0.232 100.470 -0.304
201606 -0.230 101.688 -0.298
201609 0.293 101.861 0.379
201612 0.201 101.863 0.260
201703 0.001 102.862 0.001
201706 0.121 103.349 0.154
201709 -0.005 104.136 -0.006
201712 0.125 104.011 0.158
201803 0.606 105.290 0.758
201806 0.187 106.317 0.232
201809 0.171 106.507 0.212
201812 1.424 105.998 1.770
201903 1.163 107.251 1.429
201906 0.975 108.070 1.189
201909 0.808 108.329 0.983
201912 0.634 108.420 0.771
202003 0.942 108.902 1.140
202006 0.797 108.767 0.966
202009 1.588 109.815 1.906
202012 1.388 109.897 1.664
202103 1.232 111.754 1.453
202106 1.082 114.631 1.244
202109 1.779 115.734 2.026
202112 1.665 117.630 1.865
202203 1.542 121.301 1.675
202206 1.426 125.017 1.503
202209 1.327 125.227 1.396
202212 1.204 125.222 1.267
202303 1.021 127.348 1.057
202306 1.574 128.729 1.611
202309 1.466 129.860 1.488
202312 1.345 129.419 1.369
202403 1.221 131.776 1.221

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


DiaMedica Therapeutics  (NAS:DMAC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DiaMedica Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.85/0.75
=3.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of DiaMedica Therapeutics was 9.31. The lowest was 1.01. And the median was 2.88.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


DiaMedica Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of DiaMedica Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DiaMedica Therapeutics (DiaMedica Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
301 Carlson Parkway, Suite 210, Minneapolis, MN, USA, 55305
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Executives
Jan Stahlberg 10 percent owner C/O TRILL INVEST AB, SVEAVAGEN 17 FL 18, STOCKHOLM V7 SE 111 57
Scott Kellen officer: CFO and Secretary 3405 ANNAPOLIS LANE, SUITE 200, MINNEAPOLIS MN 55447
Randall Michael Giuffre director 2 CARLSON PARKWAY, SUITE 260, MINNEAPOLIS MN 55447
Ab Trill 10 percent owner SVEAVAGEN 17, 18TH FLOOR, STOCKHOLM V7 SE-11157
Richard D. Pilnik director 2 CARLSON PARKWAY, SUITE 260, MINNEAPOLIS MN 55447
Dietrich John Pauls director, officer: President and CEO 2 CARLSON PARKWAY, SUITE 260, MINNEAPOLIS MN 55447
Richard Ii Jacinto 10 percent owner 394 SADDLE BACK TRAIL, FRANKLIN LAKES NJ 07417
David J. Wambeke officer: Chief Business Officer 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS MN 55305
Private Ab Tomeqt 10 percent owner C/O KINKON AB, BIBLIOTEKSGATAN 25, STOCKHOLM V8 11435
Koch Thomas Von 10 percent owner TOMENTERPRISE AB, BOX 5322, STOCKHOLM V7 102 47
Ab Tomenterprise 10 percent owner C/O EQT PARTNERS AB, BOX 16509, STOCKHOLM V7 103 27
Charles Pauling Semba director TWO CARLSON PARKWAY, SUITE 260, MINNEAPOLIS MN 55447
Richard Kuntz director MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Tanya Lewis director C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVE., NEWTON MA 02459
Julie Vanorsdel Daves officer: SVP Clinical Development Oper. 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS MN 55305